Literature DB >> 22336842

Saline irrigation for the management of skin extravasation injury in neonates.

P N Gopalakrishnan1, N Goel, Sujoy Banerjee.   

Abstract

BACKGROUND: Extravasation injury is a common complication of neonatal intensive care and can result in scarring with cosmetic and functional sequelae. A wide variety of treatments are used in practice including subcutaneous irrigation with saline (with or without hyaluronidase), liposuction, use of specific antidotes, different topical applications and normal wound care with dry or wet dressings. All such treatments aim to prevent or reduce the severity of complications.
OBJECTIVES: To determine the efficacy and safety of saline irrigation or saline irrigation with prior hyaluronidase infiltration on tissue healing in neonates with extravasation injury when compared to no intervention or normal wound care. SEARCH
METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2011, Issue 2), MEDLINE (1950 to June 2011), EMBASE (Jan 1980 to June 2011), CINAHL (Jan 1988 to June 2011) and the Web of Science (up to July 2011). SELECTION CRITERIA: Randomised controlled trials (RCT) and quasi-randomised controlled trials comparing saline irrigation with or without hyaluronidase infiltration with no intervention or normal wound care in the management of extravasation injury in neonates. DATA COLLECTION AND ANALYSIS: Three review authors independently reviewed and identified articles for possible inclusion in this review. MAIN
RESULTS: No eligible studies were found. There were a few case reports and case series describing successful outcomes with different interventions in this condition. AUTHORS'
CONCLUSIONS: To date, no randomised controlled trial is available that examines the effects of saline irrigation with or without prior hyaluronidase infiltration in the management of extravasation injury in neonates. Saline irrigation is a frequently reported intervention in the literature that is used in the management of extravasation injury in neonates. Research should be initially directed at evaluating the efficacy and safety of this intervention through randomised controlled trials. It will also be important to determine the size of the effect according to timing of intervention, nature of the infusate and the severity of injury at the time of intervention.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22336842     DOI: 10.1002/14651858.CD008404.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  5 in total

1.  Combined treatment with chlorhexidine and 0·9% saline in a newborn infant with an infected surgical wound.

Authors:  Kadir Şerafettin Tekgündüz; Eda Kepenekli; Yaşar Demirelli; İbrahim Caner; Mustafa Kara
Journal:  Int Wound J       Date:  2014-12-05       Impact factor: 3.315

2.  Contrast media extravasations in patients undergoing computerized tomography scanning: a systematic review and meta-analysis of risk factors and interventions.

Authors:  Sandrine Ding; Nicole Richli Meystre; Cosmin Campeanu; Giuseppe Gullo
Journal:  JBI Database System Rev Implement Rep       Date:  2018-01

Review 3.  Treating extravasation injuries in infants and young children: a scoping review and survey of UK NHS practice.

Authors:  Mark Corbett; David Marshall; Melissa Harden; Sam Oddie; Robert Phillips; William McGuire
Journal:  BMC Pediatr       Date:  2019-01-07       Impact factor: 2.125

4.  Neonatal extravasation injury: prevention and management in Australia and New Zealand-a survey of current practice.

Authors:  Matthew Restieaux; Andrew Maw; Roland Broadbent; Pam Jackson; David Barker; Ben Wheeler
Journal:  BMC Pediatr       Date:  2013-03-11       Impact factor: 2.125

Review 5.  Extravasation Injuries of the Limbs in Neonates and Children—Development of a Treatment Algorithm

Authors:  Roslind K Hackenberg; Koroush Kabir; Andreas Müller; Andreas Heydweiller; Christof Burger; Kristian Welle
Journal:  Dtsch Arztebl Int       Date:  2021-08-23       Impact factor: 8.251

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.